Product Program year 2020 Source: CMS Open Payments

Cleviprex 50Mg/100Ml

Drug Cardiovascular

NDC 10122-610-10

Open in the dashboard

General payments

$27,744

1,116 payments

Research payments

$0

0 payments

Through program year 2020, $27,744 in general payments and $0 in research payments were reported against Cleviprex 50Mg/100Ml (Cardiovascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $27,744 1,116

Breakdown

Who paid General payments · program year 2020
  1. Chiesi USA, Inc. $27,744 1,116 payments
Top recipients General payments · program year 2020
  1. Edwin Avery Anesthesiology · Cleveland, OH $3,274 12% · 8 payments
  2. Scott Brehaut Family Medicine · Clinton, NY $3,151 11% · 4 payments
  3. David Rose Neurology · Tampa, FL $501 2% · 6 payments
  4. Neema Aghamohammadi Critical Care Medicine · Carmichael, CA $229 <1% · 1 payment
  5. Nathan Gilmore Emergency Medical Services · Dana Point, CA $229 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Anesthesiology $8,668 32% · 170 practitioners
  2. Cardiovascular Disease Internal Medicine $4,549 17% · 155 practitioners
  3. Family Medicine $3,229 12% · 6 practitioners
  4. Interventional Cardiology Internal Medicine $2,672 10% · 95 practitioners
  5. Emergency Medicine $1,615 6% · 53 practitioners

The top 5 of 40 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. New York $4,413 16% · 60 recipients
  2. Ohio $3,310 12% · 3 recipients
  3. Florida $3,144 11% · 66 recipients
  4. California $2,638 10% · 45 recipients
  5. New Jersey $2,232 8% · 62 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,116 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record